Fatty acid esters of hydroxy fatty acids (FAHFAs) for use in the treatment of type 1 diabetes
US11013711B2 · kind B2 · utility
0Cited by
7References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 9, 2017 |
| Grant date | May 25, 2021 |
| Priority date | — |
| Expiry date | Jun 9, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for treating type 1 diabetes and its sequelae (e.g., cardiovascular, renal or neurologic diseases for which type 1 diabetes is a risk factor) in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a fatty acid ester of a hydroxy fatty acid (FAHFA), or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.